Results of a randomized, double-blind phase II trial of ZD6474 versus gefitinib in patients with NSCLC Meeting Abstract
| Authors: | Ranson, M.; Bodkin, D.; Govindan, R.; Sleckman, B.; Rizvi, N.; Capo, A.; Germonpre, R.; Dimery, I.; Webster, A.; Natale, R. |
| Abstract Title: | Results of a randomized, double-blind phase II trial of ZD6474 versus gefitinib in patients with NSCLC |
| Meeting Title: | 13th European Cancer Conference (ECCO 13) |
| Journal Title: | EJC Supplements |
| Volume: | 3 |
| Issue: | 2 |
| Meeting Dates: | 2005 Oct 30-Nov 3 |
| Meeting Location: | Paris, France |
| ISSN: | 1359-6349 |
| Publisher: | Pergamon-Elsevier Science Ltd |
| Date Published: | 2005-01-01 |
| Start Page: | 324 |
| End Page: | 325 |
| Language: | English |
| ACCESSION: | WOS:000247564801280 |
| PROVIDER: | wos |
| DOI: | 10.1016/S1359-6349(05)81419-3 |
| Notes: | --- - Meeting Abstract: 1124 - S - "Source: Wos" |
